Aberrant expression of SLMAP was noted in animal models of diabetes and endothelial dysfunction while genetic variants were recently defined in diabetic retinopathy in humans [29,30] and mutations in SLMAP were linked to Brugada patients [18,19]. This evidence concerns the gene SLMAP and diabetes mellitus.